Citations (58)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Sulaf Assi, Danielle Marshall, Francesco Saverio Bersani & Ornella Corazza. (2020) Uses, Effects and Toxicity of Synthetic Cannabinoids from the Perspective of People with Lived Experiences. Journal of Psychoactive Drugs 52:3, pages 237-247.
Read now
Read now
Joseph E. Carpenter, Brian Patrick Murray, Camille Dunkley, Ziad N. Kazzi & Melissa H. Gittinger. (2019) Designer benzodiazepines: a report of exposures recorded in the National Poison Data System, 2014–2017. Clinical Toxicology 57:4, pages 282-286.
Read now
Read now
Daria Piacentino, Georgios D. Kotzalidis, Livia Longo, Antonio Pavan, Luciano Stivali, Guido Stivali, Stefano Ferracuti, Roberto Brugnoli, Paola Frati, Vittorio Fineschi, Paolo Girardi & Gabriele Sani. (2017) Body Image and Eating Disorders are Common among Professional and Amateur Athletes Using Performance and Image Enhancing Drugs: A Cross-Sectional Study. Journal of Psychoactive Drugs 49:5, pages 373-384.
Read now
Read now
Diana S. Dolliver & Joseph B. Kuhns. (2016) The Presence of New Psychoactive Substances in a Tor Network Marketplace Environment. Journal of Psychoactive Drugs 48:5, pages 321-329.
Read now
Read now
Evelyn Hearne & Marie Claire Van Hout. (2016) “Trip-Sitting” in the Black Hole: A Netnographic Study of Dissociation and Indigenous Harm Reduction. Journal of Psychoactive Drugs 48:4, pages 233-242.
Read now
Read now
Articles from other publishers (53)
Giovanni Martinotti, Gilberto Di Petta, Tommaso Piro, Eleonora Chillemi & Filippo Maria Ferro. (2024) The exogenous model of psychotic experience induced by novel psychoactive substances: A clinical overview. Emerging Trends in Drugs, Addictions, and Health 4, pages 100141.
Crossref
Crossref
Rishika R. Daswani, Cassandra M. Choles, David D. Kim & Alasdair M. Barr. (2024) A systematic review and meta-analysis of synthetic cathinone use and psychosis. Psychopharmacology 241:5, pages 875-896.
Crossref
Crossref
Valerio Ricci, Giuseppe Maina & Giovanni Martinotti. (2024) The Loss of Spatiality and Temporality in Twilight Consciousness: The Emergence of Exogenous Psychosis Induced by Novel Psychoactive Substances. Psychopathology, pages 1-11.
Crossref
Crossref
Valerio Ricci, Ilenia Di Muzio, Franca Ceci, Francesco Di Carlo, Gianluca Mancusi, Tommaso Piro, Andrea Paggi, Mauro Pettorruso, Federica Vellante, Domenico De Berardis, Giovanni Martinotti & Giuseppe Maina. (2024) Aberrant salience in cannabis-induced psychosis: a comparative study. Frontiers in Psychiatry 14.
Crossref
Crossref
Roy Gerona. 2024. Designer Drugs. Designer Drugs
1
28
.
Souleiman El Balkhi & Chadi Abbara. (2023) Designer Benzodiazepines: Effects, Toxicity, and Interactions. Therapeutic Drug Monitoring 45:4, pages 494-507.
Crossref
Crossref
Michelle Jin Yee Neoh, Alessandro Carollo, Mengyu Lim, Ornella Corazza, Aurora Coppola & Gianluca Esposito. (2023) The novel psychoactive substances epidemic: A scientometric perspective. Addiction Neuroscience 5, pages 100060.
Crossref
Crossref
Chinaza Godswill Awuchi, Maduabuchi Patrick Aja, Nancy Bonareri Mitaki, Sonia Morya, Ikechukwu O. Amagwula, Chinelo Kate Echeta & Victory S. Igwe. (2023) New Psychoactive Substances: Major Groups, Laboratory Testing Challenges, Public Health Concerns, and Community-Based Solutions. Journal of Chemistry 2023, pages 1-36.
Crossref
Crossref
Alessandro Carollo, Ornella Corazza, Olivier Rabin, Aurora Coppola & Gianluca Esposito. (2023) Understanding the evolving nature of novel psychoactive substances: Mapping 10 years of research. Emerging Trends in Drugs, Addictions, and Health 3, pages 100055.
Crossref
Crossref
Minsoo Kim, Hyewon Kim, Kyungdo Han, Juhwan Yoo, Kyojin Yang & Hong Jin Jeon. (2022) Changes in alcohol consumption and the risk of cardiovascular diseases in patients with depression who had not consumed alcohol: A nationwide cohort study. Journal of Psychiatric Research 155, pages 458-464.
Crossref
Crossref
Zihong Song, Fang Dong, Yizhi Liu, Guanhua Liu, Baohua Li, Xiuyu Pang, Kang An, Dong Li, Shanshan Chen, Weijia Xing & Xizhu Xu. (2022) The Association of High-Frequency Nut Intake With a Low Risk of Psychological Problems in Female Methamphetamine Users. Frontiers in Psychiatry 13.
Crossref
Crossref
Andrea Di Nicola. (2022) Towards digital organized crime and digital sociology of organized crime. Trends in Organized Crime.
Crossref
Crossref
Pierluigi Simonato, Angela Scoppettone, Francesco Saverio Bersani & Silvia Rossato. 2022. Emerging Drugs in Sport. Emerging Drugs in Sport
151
159
.
Eun Yong Chung, Hye Jin Cha, Hyun Kyu Min & Jaesuk Yun. (2021) Pharmacology and adverse effects of new psychoactive substances: synthetic cannabinoid receptor agonists. Archives of Pharmacal Research 44:4, pages 402-413.
Crossref
Crossref
Giovanni Martinotti, Luisa De Risio, Chiara Vannini, Fabrizio Schifano, Mauro Pettorruso & Massimo Di Giannantonio. (2020) Substance-related exogenous psychosis: a postmodern syndrome. CNS Spectrums 26:1, pages 84-91.
Crossref
Crossref
Katherine Sanchez, Jan Gryczynski, Steven B. Carswell & Robert P. Schwartz. (2021) Development and Feasibility of a Spanish Language Version of the Tobacco, Alcohol, Prescription Drug, and Illicit Substance Use (TAPS) Tool. Journal of Addiction Medicine 15:1, pages 61-67.
Crossref
Crossref
K.P.C. Kuypers, F.S. Bersani, R. Bruno, B.K. Vicknasingam, A. Roman-Urrestarazu & O. Corazza. (2021) Introducing the new open access Journal Emerging Trends in Drugs, Addiction, and Health. Emerging Trends in Drugs, Addictions, and Health 1, pages 100001.
Crossref
Crossref
Nevriye A. YesilNevriye A. Yesil. 2021. Drogen haben kurze Beine. Drogen haben kurze Beine
71
103
.
Giovanni Martinotti, Attilio Negri, Stefania Schiavone, Chiara Montemitro, Chiara Vannini, Gaia Baroni, Mauro Pettorruso, Fabio De Giorgio, Raffaele Giorgetti, Valeria Verrastro, Luigia Trabace, Andres Garcia, Ivan Castro, Juan Iglesias Lopez, Cristina Merino Del Villar, Fabrizio Schifano & Massimo di Giannantonio. (2020) Club Drugs: Psychotropic Effects and Psychopathological Characteristics of a Sample of Inpatients. Frontiers in Psychiatry 11.
Crossref
Crossref
Eva Drapalova, Vendula Belackova & Agnès Cadet‐Taïrou. (2020) How to ask about the use of new psychoactive substances to increase the validity of results in self‐report prevalence surveys. Drug and Alcohol Review 39:3, pages 278-286.
Crossref
Crossref
Gabriele BarattoGabriele Baratto. 2020. The Illegal Trade of Medicines on Social Media. The Illegal Trade of Medicines on Social Media
7
35
.
Amy Peacock, Raimondo Bruno, Natasa Gisev, Louisa Degenhardt, Wayne Hall, Roumen Sedefov, Jason White, Kevin V Thomas, Michael Farrell & Paul Griffiths. (2019) New psychoactive substances: challenges for drug surveillance, control, and public health responses. The Lancet 394:10209, pages 1668-1684.
Crossref
Crossref
Luca Zamengo, Giampietro Frison & Guus Zwitser. (2018) Understanding and managing the new psychoactive substances phenomenon: a holistic approach. Journal of Public Health Policy 40:2, pages 217-235.
Crossref
Crossref
Kirsten E. Smith & William W. Stoops. (2019) Synthetic Cathinone Use Among Polysubstance Users: Indirect Indicator of Indiscriminate Drug Taking or Preferred Drug of Abuse?. Journal of Drug Issues 49:2, pages 369-386.
Crossref
Crossref
Cristina Miliano, Giulia Margiani, Liana Fattore & Maria De Luca. (2018) Sales and Advertising Channels of New Psychoactive Substances (NPS): Internet, Social Networks, and Smartphone Apps. Brain Sciences 8:7, pages 123.
Crossref
Crossref
Giovanni Martinotti, Rita Santacroce, Mauro Pettorruso, Chiara Montemitro, Maria Spano, Marco Lorusso, Massimo di Giannantonio & Arturo Lerner. (2018) Hallucinogen Persisting Perception Disorder: Etiology, Clinical Features, and Therapeutic Perspectives. Brain Sciences 8:3, pages 47.
Crossref
Crossref
Jolanta B. Zawilska & Jakub Wojcieszak. 2018. Synthetic Cathinones. Synthetic Cathinones
11
24
.
Kyle H Bennett, Helen M Hare, Robert M Waller, Helen L Alderson & Stephen Lawrie. (2017) Characteristics of NPS use in patients admitted to acute psychiatric services in Southeast Scotland: a retrospective cross-sectional analysis following public health interventions. BMJ Open 7:12, pages e015716.
Crossref
Crossref
Deivisson Lopes Cunha, Frederico Goytacazes de Araujo & Marcia Marques. (2017) Psychoactive drugs: occurrence in aquatic environment, analytical methods, and ecotoxicity—a review. Environmental Science and Pollution Research 24:31, pages 24076-24091.
Crossref
Crossref
Noreen D Mdege, Nick Meader, Charlie Lloyd, Steve Parrott & Jim McCambridge. (2017) The Novel Psychoactive Substances in the UK Project: empirical and conceptual review work to produce research recommendations. Public Health Research 5:4, pages 1-138.
Crossref
Crossref
Máté Kapitány‐Fövény, Judit Farkas, Patrícia Andrea Pataki, Anna Kiss, Janka Horváth, Róbert Urbán & Zsolt Demetrovics. (2017) Novel psychoactive substance use among treatment‐seeking opiate users: The role of life events and psychiatric symptoms. Human Psychopharmacology: Clinical and Experimental 32:3.
Crossref
Crossref
Isabella Canazza, Andrea Ossato, Fabrizio Vincenzi, Adolfo Gregori, Fabiana Di Rosa, Federica Nigro, Alessandro Rimessi, Paolo Pinton, Katia Varani, Pier Andrea Borea & Matteo Marti. (2017)
Pharmaco‐toxicological effects of the novel third‐generation fluorinate synthetic cannabinoids,
5F‐ADBINACA
,
AB‐FUBINACA
, and
STS‐135
in mice. In vitro and in vivo studies
. Human Psychopharmacology: Clinical and Experimental 32:3.
Crossref
Crossref
Giovanni Martinotti, Eduardo Cinosi, Rita Santacroce, Duccio Papanti, Anna Pasquini, Valerio Mancini, Mariangela Corbo, Federica Fiori, Fabiola Sarchione, Daniela Marchetti, Maria Cristina Verrocchio, Massimo Di Giannantonio, Marta Torrens, Fabrizio Schifano, Maria Jose Morlan Coarasa & Cristina Merino del Villar. (2017) Substance‐related psychopathology and aggressiveness in a nightlife holiday resort: Results from a pilot study in a psychiatric inpatient unit in Ibiza. Human Psychopharmacology: Clinical and Experimental 32:3.
Crossref
Crossref
Pierluigi Simonato, Francesco S. Bersani, Rita Santacroce, Eduardo Cinosi, Fabrizio Schifano, Giuseppe Bersani, Giovanni Martinotti & Ornella Corazza. (2017) Can mobile phone technology support a rapid sharing of information on novel psychoactive substances among health and other professionals internationally?. Human Psychopharmacology: Clinical and Experimental 32:3.
Crossref
Crossref
Laura Orsolini, Duccio Papanti, John Corkery & Fabrizio Schifano. (2017) An insight into the deep web; why it matters for addiction psychiatry?. Human Psychopharmacology: Clinical and Experimental 32:3.
Crossref
Crossref
John Martin Corkery, Laura Orsolini, Duccio Papanti & Fabrizio Schifano. (2017) From concept(ion) to life after death/the grave: The ‘natural’ history and life cycle(s) of novel psychoactive substances (NPS). Human Psychopharmacology: Clinical and Experimental 32:3.
Crossref
Crossref
Anna Fantinati, Andrea Ossato, Sara Bianco, Isabella Canazza, Fabio De Giorgio, Claudio Trapella & Matteo Marti. (2017) 1‐cyclohexyl‐x‐methoxybenzene derivatives, novel psychoactive substances seized on the internet market. Synthesis and in vivo pharmacological studies in mice. Human Psychopharmacology: Clinical and Experimental 32:3.
Crossref
Crossref
Major Gooyit, Pedro O. Miranda, Cody J. Wenthur, Alex Ducime & Kim D. Janda. (2016) Influencing Antibody-Mediated Attenuation of Methamphetamine CNS Distribution through Vaccine Linker Design. ACS Chemical Neuroscience 8:3, pages 468-472.
Crossref
Crossref
Luigi Laura & Gianluigi Me. (2015) Searching the Web for illegal content: the anatomy of a semantic search engine. Soft Computing 21:5, pages 1245-1252.
Crossref
Crossref
Alexander Soderholm. 2017. Novel Psychoactive Substances. Novel Psychoactive Substances
75
95
.
Liana Fattore & Marco Diana. (2016) Drug addiction: An affective-cognitive disorder in need of a cure. Neuroscience & Biobehavioral Reviews 65, pages 341-361.
Crossref
Crossref
Cristina Miliano, Giovanni Serpelloni, Claudia Rimondo, Maddalena Mereu, Matteo Marti & Maria Antonietta De Luca. (2016) Neuropharmacology of New Psychoactive Substances (NPS): Focus on the Rewarding and Reinforcing Properties of Cannabimimetics and Amphetamine-Like Stimulants. Frontiers in Neuroscience 10.
Crossref
Crossref
Francesco Saverio Bersani, Rita Santacroce, Marialuce Coviello, Claudio Imperatori, Marta Francesconi, Roberto Vicinanza, Amedeo Minichino & Ornella Corazza. (2015) Cannabis: a self‐medication drug for weight management? The never ending story. Drug Testing and Analysis 8:2, pages 177-179.
Crossref
Crossref
Jolanta B. Zawilska & Dariusz Andrzejczak. (2015) Next generation of novel psychoactive substances on the horizon – A complex problem to face. Drug and Alcohol Dependence 157, pages 1-17.
Crossref
Crossref
Svante Vikingsson, Martin Josefsson & Henrik Gréen. (2015) Identification of AKB-48 and 5F-AKB-48 Metabolites in Authentic Human Urine Samples Using Human Liver Microsomes and Time of Flight Mass Spectrometry. Journal of Analytical Toxicology 39:6, pages 426-435.
Crossref
Crossref
Kathleen Meyers, Övgü Kaynak, Elena Bresani, Brenda Curtis, Ashley McNamara, Kristine Brownfield & Kimberly C. Kirby. (2015) The availability and depiction of synthetic cathinones (bath salts) on the Internet: Do online suppliers employ features to maximize purchases?. International Journal of Drug Policy 26:7, pages 670-674.
Crossref
Crossref
Qiu Ting Chie, Cai Lian Tam, Gregory Bonn, Chee Piau Wong, Hoang Minh Dang & Rozainee Khairuddin. (2015) Drug Abuse, Relapse, and Prevention Education in Malaysia: Perspective of University Students Through a Mixed Methods Approach. Frontiers in Psychiatry 6.
Crossref
Crossref
Caroline Anderson, Christopher Morrell & David Marchevsky. (2015) A novel psychoactive substance poses a new challenge in the management of paranoid schizophrenia. BMJ Case Reports, pages bcr2015209573.
Crossref
Crossref
Andreas H. Laustsen, Bruno Lomonte, Brian Lohse, Julián Fernández & José María Gutiérrez. (2015) Unveiling the nature of black mamba (Dendroaspis polylepis) venom through venomics and antivenom immunoprofiling: Identification of key toxin targets for antivenom development. Journal of Proteomics 119, pages 126-142.
Crossref
Crossref
Eduardo Cinosi, Giovanni Martinotti, Pierluigi Simonato, Darshan Singh, Zsolt Demetrovics, Andres Roman-Urrestarazu, Francesco Saverio Bersani, Balasingam Vicknasingam, Giulia Piazzon, Jih-Heng Li, Wen-Jing Yu, Máté Kapitány-Fövény, Judit Farkas, Massimo Di Giannantonio & Ornella Corazza. (2015)
Following “the Roots” of Kratom (
Mitragyna speciosa
): The Evolution of an Enhancer from a Traditional Use to Increase Work and Productivity in Southeast Asia to a Recreational Psychoactive Drug in Western Countries
. BioMed Research International 2015, pages 1-11.
Crossref
Crossref
F. Saverio Bersani, Marialuce Coviello, Claudio Imperatori, Marta Francesconi, Christina M. Hough, Giuseppe Valeriani, Gianfranco De Stefano, Flaminia Bolzan Mariotti Posocco, Rita Santacroce, Amedeo Minichino & Ornella Corazza. (2015) Adverse Psychiatric Effects Associated with Herbal Weight-Loss Products. BioMed Research International 2015, pages 1-10.
Crossref
Crossref
Jolanta B. Zawilska. 2015. The Neuropsychiatric Complications of Stimulant Abuse. The Neuropsychiatric Complications of Stimulant Abuse
273
300
.
Luigi Laura & Gianluigi Me. 2015. Global Security, Safety and Sustainability: Tomorrow's Challenges of Cyber Security. Global Security, Safety and Sustainability: Tomorrow's Challenges of Cyber Security
113
122
.